title: [Substance P in antitumor drug-induced adverse reactions].
authors.forename: Takahisa
authors.initials: T
authors.lastname: Yano
authors.forename: Takehiro
authors.initials: T
authors.lastname: Kawashiri
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Egashira
authors.forename: Ryozo
authors.initials: R
authors.lastname: Oishi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016190:Carboplatin / Q000009:adverse effects*; D006633:Histamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control*; D009479:Neuropeptides / Q000378:metabolism / Q000502:physiology; D017239:Paclitaxel / Q000009:adverse effects*; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use; D013373:Substance P / Q000378:metabolism / Q000502:physiology*; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D006633:Histamine Antagonists; D009479:Neuropeptides; D011725:Pyridines; D011744:Pyrimidinones; C055139:pemirolast; D013373:Substance P; D016190:Carboplatin; D017239:Paclitaxel